Therefore, in addition to transcriptional activation, it was suggested that the apparent upregulation of NOXA in MM cells after BTZ plus CAM treatment appeared to be due to the concomitant inhibition of proteasomes with BTZ and autophagy with CAM (Fig 3A). The gene discussed is CASC3; the disease is Miyoshi myopathy.